Sam Brusco, Associate Editor11.02.22
Smith+Nephew introduced its new JOURNEY II ROX total knee, a reverse hybrid construct for total knee arthroplasty.
The new knee has an advanced bearing material and anatomic design, combined with the efficiency and potential long-term tibia fixation of a cementless knee.
JOURNEY II ROX is compatible with S+N’s CORI surgical system, allowing surgeons access to next-gen robotic-assisted technology.
"The reverse hybrid combination provides my patients with a powerful collection of knee arthroplasty technologies. The kinematic functionality of JOURNEY II, the biocompatibility and longevity benefits of an oxidized zirconium alloy femoral component in OXINIUM and now CONCELOC," Dr. Steven B. Haas, Chief, the Knee Service and John N. Insall Chair, Knee Surgery at the Hospital for Special Surgery in New York, told the press. "CONCELOC offers the potential to achieve osseointegration where it is needed – the tibia and patellae. It's an evidence-based approach to knee arthroplasty that utilizes high performance technologies delivered with the operative time savings recognized in a complete cementless procedure."
"The reverse hybrid technique works very well in my hands and I'm able to ensure my patients have the opportunity to harness the JOURNEY II knee mechanics for a more natural knee function," added Dr. Matthew Bullock, Associate Professor of Orthopedic Surgery, Marshall University, Joan C. Edwards School of Medicine. "The hybrid approach does not add time to my cases—in fact, I find that using the porous tibia and patella components reduces my operative time by approximately 15 minutes instead of waiting for cement to cure."
"Driving procedural innovation to help surgeons treat patients and provide better outcomes is the core of our purpose—Life Unlimited," said Randy Kilburn, executive VP and GM, Global Joint Reconstruction and Robotics at Smith+Nephew. "The JOURNEY II ROX Total Knee Solution underscores this by bringing together high performance components to deliver a custom procedural solution that no other company offers."
S+N will preview JOURNEY II ROX at its booth (501) at this year’s Annual Meeting of the American Association of Hip and Knee Surgeons (AAHKS).
The new knee has an advanced bearing material and anatomic design, combined with the efficiency and potential long-term tibia fixation of a cementless knee.
JOURNEY II ROX is compatible with S+N’s CORI surgical system, allowing surgeons access to next-gen robotic-assisted technology.
"The reverse hybrid combination provides my patients with a powerful collection of knee arthroplasty technologies. The kinematic functionality of JOURNEY II, the biocompatibility and longevity benefits of an oxidized zirconium alloy femoral component in OXINIUM and now CONCELOC," Dr. Steven B. Haas, Chief, the Knee Service and John N. Insall Chair, Knee Surgery at the Hospital for Special Surgery in New York, told the press. "CONCELOC offers the potential to achieve osseointegration where it is needed – the tibia and patellae. It's an evidence-based approach to knee arthroplasty that utilizes high performance technologies delivered with the operative time savings recognized in a complete cementless procedure."
"The reverse hybrid technique works very well in my hands and I'm able to ensure my patients have the opportunity to harness the JOURNEY II knee mechanics for a more natural knee function," added Dr. Matthew Bullock, Associate Professor of Orthopedic Surgery, Marshall University, Joan C. Edwards School of Medicine. "The hybrid approach does not add time to my cases—in fact, I find that using the porous tibia and patella components reduces my operative time by approximately 15 minutes instead of waiting for cement to cure."
"Driving procedural innovation to help surgeons treat patients and provide better outcomes is the core of our purpose—Life Unlimited," said Randy Kilburn, executive VP and GM, Global Joint Reconstruction and Robotics at Smith+Nephew. "The JOURNEY II ROX Total Knee Solution underscores this by bringing together high performance components to deliver a custom procedural solution that no other company offers."
S+N will preview JOURNEY II ROX at its booth (501) at this year’s Annual Meeting of the American Association of Hip and Knee Surgeons (AAHKS).